David Mountcastle - 21 Jul 2022 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Role
EVP & Chief Financial Officer
Signature
/s/ Thomas Bartrum, as attorney-in fact
Issuer symbol
PRVA
Transactions as of
21 Jul 2022
Transactions value $
-$250,993
Form type
4
Filing time
25 Jul 2022, 16:11:09 UTC
Previous filing
19 Jul 2022
Next filing
08 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRVA Common Stock, par value $0.01 per share Options Exercise $14.6K +7.32K +6.13% $2.00* 127K 21 Jul 2022 Direct
transaction PRVA Common Stock, par value $0.01 per share Sale -$266K -7.32K -5.78% $36.27 119K 21 Jul 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRVA Stock Option (Right to Purchase) Options Exercise $0 -7.32K -17.52% $0.00 34.5K 21 Jul 2022 Common Stock 7.32K $2.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.96 to $36.65 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3 Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 24,568 of the stock options are fully vested and exercisable. 17,244 of the stock options will vest on October 29, 2022.